Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas

Endocrine Pathology

Volumn 15, Issue 1, 2004, Pages 17-27

  Onguru, Onder ^a,b   Scheithauer, Bernd W ^b   Kovacs, Kalman ^c   Vidal, Sergio ^c   Jin, Long ^b   Zhang, Shuya ^b   Ruebel, Katharina H ^b   Lloyd, Ricardo V ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b MAYO CLINIC   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cox 2; Immunohistochemistry; Pituitary adenoma; Pituitary carcinoma; RT PCR; Thromboxane synthase

Indexed keywords

CYCLOOXYGENASE 2; THROMBOXANE SYNTHASE;

ARTICLE; CARCINOMA; CONTROLLED STUDY; ENZYME METABOLISM; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION;

BLOTTING, WESTERN; CARCINOMA; CYCLOOXYGENASE 2; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTINOMA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOXANE-A SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 3242669516     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:15:1:17     Document Type: Article

References (48)

1. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120, 1998.
2. Bjorkman DJ. The effect of aspirin and non-steroidal anti-inflammatory drugs on prostaglandins. Am J Med 27;105(1B):8S-12S, 1998.
3. Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270(3 Pt 1):G393-400, 1996.
4. Morita I, Schindler M, Regier MK, et al. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270(18):10902-10908, 1995.
5. Smith WL, DeWitt DL. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 15(3):179-194, 1995.
6. Hamberg M, Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci USA 70(3):899-903, 1973.
7. Ogletree ML. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 46(1):133-138, 1987.
8. Tone Y, Miyata A, Hara S, Yukawa S, Tanabe T. Abundant expression of thromboxane synthase in rat macrophages. FEBS Lett 340(3):241-244, 1994.
9. Jones DA, Fitzpatrick FA. "Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets. J Biol Chem 265(33):20166-20171, 1990.
10. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 55:69-102, 1986.
11. Hirata M, Hayashi Y, Ushikubi F, et al. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349(6310): 617-620, 1991.
12. Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5(12):1418-1423, 1999.
13. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93(5):705-716, 1998.
14. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59(18):4574-4577, 1999.
15. Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60(5):1306-1311, 2000.
16. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105(11): 1589-1594, 2000.
17. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94(7):3336-3340, 1997.
18. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83(3):493-501, 1995.
19. Harris RE, Robertson FM, Abou-Issa HM, Farrar WB, Brueggemeier R. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Med Hypotheses 52(4):291-292, 1999.
20. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1(1):11-21, 2001.
21. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55(17): 3785-3789, 1995.
22. Dixon DA. Regulation of COX-2 expression in human cancers. Prog Exp Tumor Res 37:52-71, 2003.
23. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87(5):803-809, 1996.
24. Liu CH, Chang SH, Narko K, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276(21):18563-18569, 2001.
25. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA 98(13):7629-7634, 2001.
26. Drago JR, Al-Mondhiry HA. The effect of prostaglandin modulators on prostate tumor growth and metastasis. Anticancer Res 4(6):391-394, 1984.
27. Nie D, Lamberti M, Zacharek A, et al. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun 267(1): 245-251, 2000.
28. Vidal S, Kovacs K, Bell D, Horvath E, Scheithauer BW, Lloyd RV. Cyclooxygenase-2 expression in human pituitary tumors. Cancer 97(11):2814-2821, 2003.
29. Bloomer CW, Kenyon L, Hammond E, et al. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas. Am J Clin Oncol 26(4):S75-80, 2003.
30. Altorki NK, Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract. Prog Exp Tumor Res 37:107-123, 2003.
31. Ihara H, Yokoyama C, Miyata A, et al. Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester. FEBS Lett 306(2-3):161-164, 1992.
32. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4(7):844-847.
33. Jin L, Zhang S, Bayliss J, et al. Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies. Endocr Pathol 14(1):37-48, 2003.
34. Jin L, Kulig E, Qian X, et al. Distribution and regulation of proconvertases PC1 and PC2 in human pituitary adenomas. Pituitary 1(3-4): 187-195, 1999.
35. Lloyd RV, Jin L, Qian X, Kulig E. Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 150(2):401-407, 1997.
36. DuBois RN. Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res 37:124-137, 2003.
37. Dannenberg AJ, Howe LR. The role of COX-2 in breast and cervical cancer. Prog Exp Tumor Res 37:90-106, 2003.
38. Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res 6(6):2513-2520, 2000.
39. Saha D, Choy H. Potential for combined modality therapy of cyclooxygenase inhibitors and radiation. Prog Exp Tumor Res 37:193-209, 2003.
40. Kurzel F, Hagel Ch, Zapf S, Meissner H, Westphal M, Giese A. Cyclo-oxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells. Acta Neurochir (Wien) 144(1):71-87, 2002.
41. Bing RJ, Miyataka M, Rich KA, et al. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin Cancer Res 7(11):3385-3392, 2001.
42. McDonough W, Tran N, Giese A, Norman SA, Berens ME. Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 57(5):449-455, 1998
43. Giese A, Hagel C, Kim EL, et al. Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro-oncol 1(1):3-13, 1999.
44. Castelli MG, Chiabrando C, Fanelli R, et al. Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res 49(6):1505-1508, 1989.
45. Pradono P, Tazawa R, Maemondo M, et al. Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 62(1):63-66, 2002.
46. Brock TG, McNish RW, Peters-Golden M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem 274(17):11660-11666, 1999.
47. Wood CE, Purinton S, Cudd TA. Immunoreactive thromboxane synthase is measurable in ovine fetal hypothalamus as early as 86 days' gestation. Prostaglandins 54(2):569-579, 1997.
48. Husted D, Upshaw J, Gridley KE, Wood CE. Cellular localization of thromboxane synthase in ovine spinal cord and hindbrain. Brain Res 971(1):107-115, 2003.